Advertisement

Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings

  • R. C. Caylor
  • L. Grote
  • I. Thiffault
  • E. G. Farrow
  • L. Willig
  • S. Soden
  • S. M. Amudhavalli
  • A. J. Nopper
  • K. A. Horii
  • E. Fleming
  • J. Jenkins
  • H. Welsh
  • M. Ilyas
  • K. Engleman
  • A. Abdelmoity
  • C. J. Saunders
Original Article

Abstract

Tuberous sclerosis complex (TSC) is an autosomal-dominant neurocutaneous disorder characterized by lesions and benign tumors in multiple organ systems including the brain, skin, heart, eyes, kidneys, and lungs. The phenotype is highly variable, although penetrance is reportedly complete. We report the molecular diagnosis of TSC in individuals exhibiting extreme intra-familial variability, including the incidental diagnosis of asymptomatic family members. Exome sequencing was performed in three families, with probands referred for epilepsy, autism, and absent speech (Family 1); epileptic spasms (Family 2); and connective tissue disorders (Family 3.) Pathogenic variants in TSC1 or TSC2 were identified in nine individuals, including relatives with limited or no medical concerns at the time of testing. Of the nine individuals reported here, six had post-diagnosis examinations and three met clinical diagnostic criteria for TSC. One did not meet clinical criteria for a possible or definite diagnosis of TSC, and two had only a possible clinical diagnosis following post-diagnosis workup. These individuals as well as their mothers demonstrated limited features that would not raise concern for TSC in the absence of molecular results. In addition, three individuals exhibited epilepsy with normal brain MRIs, and two without seizures or intellectual disability had MRI findings fulfilling major criteria for TSC highlighting the difficulty providers face when relying on clinical criteria to guide genetic testing. Given the importance of a timely TSC diagnosis for clinical management, such cases demonstrate a potential benefit for clinical criteria to include seizures and an unbiased molecular approach to genetic testing.

Keywords

Exome sequencing TSC1 TSC2 Tuberous sclerosis complex Atypical phenotype Incidental finding Asymptomatic Molecular diagnosis Genetic counseling 

Abbreviations

TSC

tuberous sclerosis complex

WES

whole exome sequencing

Notes

Acknowledgements

We gratefully acknowledge the families for their participation and our colleagues in the Center for Pediatric Genomic Medicine.

Author contributions

R.C.C. wrote first draft of manuscript; L.G. and K.E. counseled and consented patients; I.T. participated in the laboratory oversight and molecular analysis; E.F. participated in the laboratory oversight and analysis; L.W., A.N., A.A, and M.I. treated the patients and edited the manuscript. C.S participated in the oversight of study and preparation of the first draft. All authors participated in revising the manuscript and approved the submission.

Funding

This work was supported by Children’s Mercy Hospitals Kansas City, the Marion Merrell Dow Foundation, Pat and Gil Clements Foundation, and Claire Giannini Foundation.

Compliance with ethical standards

Ethics approval and consent to participate

Written informed consent of participation was obtained from the participants. A copy of the written consent is available for review by the Editor of this journal. Approval of case reports is waived by the Institutional Review Board.

Consent for publication

Written informed consent to publish this case series was given by the patients and their legal guardians.

Competing interests

The authors declare that they have no competing interests.

References

  1. 1.
    Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 615:125–127CrossRefPubMedGoogle Scholar
  2. 2.
    Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1998) Renal lesion growth in children with tuberous sclerosis complex. J Urol 160(1):141–145CrossRefPubMedGoogle Scholar
  3. 3.
    Lyczkowski DA, Conant KD, Pulsifer MB, Jarrett DY, Grant PE, Kwiatkowski DJ, Thiele EA (2007) Intrafamilial phenotypic variability in tuberous sclerosis complex. J Child Neurol 22(12):1348–1355.  https://doi.org/10.1177/0883073807307093 CrossRefPubMedGoogle Scholar
  4. 4.
    Humphrey A, Higgins JN, Yates JR, Bolton PF (2004) Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits. Neurology 62(5):795–798CrossRefPubMedGoogle Scholar
  5. 5.
    Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372(9639):657–668.  https://doi.org/10.1016/S0140-6736(08)61279-9 CrossRefPubMedGoogle Scholar
  6. 6.
    Caban C, Khan N, Hasbani DM, Crino PB (2017) Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet 10:1–8.  https://doi.org/10.2147/TACG.S90262 CrossRefPubMedGoogle Scholar
  7. 7.
    Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus G (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49(4):243–254.  https://doi.org/10.1016/j.pediatrneurol.2013.08.001 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus G (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49(4):255–265.  https://doi.org/10.1016/j.pediatrneurol.2013.08.002 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphray S, Saffrey P, Kingsbury Z, Weir JC, Betley J, Grocock RJ, Margulies EH, Farrow EG, Artman M, Safina NP, Petrikin JE, Hall KP, Kingsmore SF (2012) Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 4(154):154ra135.  https://doi.org/10.1126/scitranslmed.3004041 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon JB, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF (2014) Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 6(265):265ra168.  https://doi.org/10.1126/scitranslmed.3010076 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Curatolo P, Verdecchia M, Bombardieri R (2002) Tuberous sclerosis complex: a review of neurological aspects. Eur J Paediatr Neurol 6(1):15–23.  https://doi.org/10.1053/ejpn.2001.0538 CrossRefPubMedGoogle Scholar
  12. 12.
    Rosset C, Netto CBO, Ashton-Prolla P (2017) TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review. Genet Mol Biol 40(1):69–79.  https://doi.org/10.1590/1678-4685-GMB-2015-0321 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kingswood JC, d’Augeres GB, Belousova E, Ferreira JC, Carter T, Castellana R, Cottin V, Curatolo P, Dahlin M, de Vries PJ, Feucht M, Fladrowski C, Gislimberti G, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Nabbout R, O’Callaghan F, Benedik MP, Qin J, Marques R, Sander V, Sauter M, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Jansen AC, Consortium T, Investigators T (2017) TuberOus SClerosis registry to increase disease Awareness (TOSCA)—baseline data on 2093 patients. Orphanet J Rare Dis 12(1):2.  https://doi.org/10.1186/s13023-016-0553-5 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Davis PE, Filip-Dhima R, Sideridis G, Peters JM, Au KS, Northrup H, Bebin EM, Wu JY, Krueger D, Sahin M, Tuberous Sclerosis Complex Autism Center of Excellence Research N (2017) Presentation and diagnosis of tuberous sclerosis complex in infants. Pediatrics 140(6):e20164040.  https://doi.org/10.1542/peds.2016-4040 CrossRefPubMedGoogle Scholar
  15. 15.
    Curatolo P, Moavero R, de Vries PJ (2015) Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 14(7):733–745.  https://doi.org/10.1016/s1474-4422(15)00069-1 CrossRefPubMedGoogle Scholar
  16. 16.
    Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA (2010) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51(7):1236–1241.  https://doi.org/10.1111/j.1528-1167.2009.02474.x CrossRefPubMedGoogle Scholar
  17. 17.
    Swallow E, King S, Song J, Peeples M, Signorovitch JE, Liu Z, Prestifilippo J, Frost M, Kohrman M, Korf B, Krueger D, Sparagana S (2017) Patterns of disease monitoring and treatment among patients with tuberous sclerosis complex-related angiomyolipomas. Urology 104:110–114.  https://doi.org/10.1016/j.urology.2017.02.036 CrossRefPubMedGoogle Scholar
  18. 18.
    Fox J, Ben-Shachar S, Uliel S, Svirsky R, Saitsu H, Matsumoto N, Fattal-Valevski A (2017) Rare familial TSC2 gene mutation associated with atypical phenotype presentation of tuberous sclerosis complex. Am J Med Genet A 173(3):744–748.  https://doi.org/10.1002/ajmg.a.38027 CrossRefPubMedGoogle Scholar
  19. 19.
    Nakano H, Otsuka A, Kinoshita M (2015) A subtle case of tuberous sclerosis complex. Epilepsy Behav Case Rep 4:88–90.  https://doi.org/10.1016/j.ebcr.2015.08.002 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Gosein MA, Ameeral A, Konduru SK, Dola VN (2013) Tuberous sclerosis presenting with spontaneous pneumothorax secondary to lymphangioleiomyomatosis; previously mistaken for asthma. BMJ Case Rep 2013:bcr2013009969.  https://doi.org/10.1136/bcr-2013-009969 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(Pt 20):3589–3594.  https://doi.org/10.1242/jcs.051011 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Caprez C, Walling AD, Reimer CM (2004) Tuberous sclerosis complex in a young woman diagnosed incidentally on the basis of pregnancy ultrasonography. South Med J 97(5):512–515CrossRefPubMedGoogle Scholar
  23. 23.
    Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19(2):249–255.  https://doi.org/10.1038/gim.2016.190 CrossRefPubMedGoogle Scholar
  24. 24.
    Jeong A, Wong M (2016) Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex. Epilepsia 57(9):1443–1449.  https://doi.org/10.1111/epi.13467 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018
corrected publication July/2018

Authors and Affiliations

  • R. C. Caylor
    • 1
  • L. Grote
    • 2
    • 3
  • I. Thiffault
    • 1
    • 4
    • 5
  • E. G. Farrow
    • 4
    • 3
    • 5
  • L. Willig
    • 4
    • 6
    • 3
    • 5
  • S. Soden
    • 4
    • 3
    • 5
  • S. M. Amudhavalli
    • 2
    • 3
    • 5
  • A. J. Nopper
    • 7
    • 3
    • 5
  • K. A. Horii
    • 7
    • 3
    • 5
  • E. Fleming
    • 2
    • 3
  • J. Jenkins
    • 2
    • 3
  • H. Welsh
    • 2
    • 3
  • M. Ilyas
    • 8
    • 3
    • 5
  • K. Engleman
    • 2
    • 3
  • A. Abdelmoity
    • 8
    • 3
    • 5
  • C. J. Saunders
    • 1
    • 4
    • 5
  1. 1.Department of Pathology and Laboratory MedicineChildren’s Mercy HospitalsKansas CityUSA
  2. 2.Division of Clinical GeneticsChildren’s Mercy HospitalsKansas CityUSA
  3. 3.Department of PediatricsChildren’s Mercy HospitalsKansas CityUSA
  4. 4.Center for Pediatric Genomic MedicineChildren’s Mercy HospitalsKansas CityUSA
  5. 5.University of Missouri-Kansas City School of MedicineKansas CityUSA
  6. 6.Division of NephrologyChildren’s Mercy HospitalsKansas CityUSA
  7. 7.Division of DermatologyChildren’s Mercy HospitalsKansas CityUSA
  8. 8.Division of NeurologyChildren’s Mercy HospitalsKansas CityUSA

Personalised recommendations